Scynexis antifungal drug secures FDA nod; first approval in new class in 20 years June 2, 2021 Auto Bot BioPharma, biopharma nl, Clinical Trials, FDA, New Jersey, Pharma 0 The FDA has approved Brexafemme, a Scynexis antifungal drug, for treating vaginal yeast infections. The drug is the biotech’s first FDA-approved product and it also represents the first new antifungal drug class in 20 years.